FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to a method of diagnosing Alzheimer's disease or a mild cognitive impairment. The essence of the method consists in the fact than the method includes the measurement of desmosterol, beta-amyloid, and gelsolin in blood. If the desmosterol level in the subject's blood is below the standard value, or if the desmosterol level and Aβx-42 or Aβx-42/Aβx-40 in the subject's blood are below the standard values, or if the desmosterol level and Aβx-42 or Aβx-42/Aβx-40 and the level of helsolin in the subject's blood are below the standard values, Alzheimer's disease or a mild cognitive impairment are diagnosed.
EFFECT: application of the claimed method makes it possible to effectively diagnose Alzheimer's disease or a mild cognitive impairment.
4 cl, 8 dwg, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IDENTIFYING A GROUP OF PEOPLE WITH AN INCREASED RISK OF DEVELOPING ALZHEIMER'S DISEASE | 2021 |
|
RU2781612C1 |
| APPLICATION OF THERAPEUTIC HUMAN ALBUMIN FOR PREPARING DRUG FOR TREATING PATIENTS SUFFERING COGNITIVE DISORDERS | 2008 |
|
RU2414925C2 |
| HUMANISED ANTIBODIES TO β-AMYLOID PEPTIDE | 2008 |
|
RU2475500C2 |
| METHODS OF TREATING ALZHEIMER'S DISEASE | 2015 |
|
RU2720468C2 |
| METHOD FOR DIAGNOSING OR DETERMINING THE RISK OF DEVELOPING COGNITIVE IMPAIRMENT | 2023 |
|
RU2821890C1 |
| METHOD OF USE IN THERAPY | 2010 |
|
RU2579659C2 |
| SYNTHETIC TETRAPEPTIDE HAEE AND DERIVATIVES THEREOF INTENDED FOR PROTECTION OF HUMAN NEURON FUNCTION | 2023 |
|
RU2822602C1 |
| HAEE SYNTHETIC TETRAPEPTIDE AND DERIVATIVES THEREOF INTENDED FOR HUMAN NEURON FUNCTION RECOVERY | 2023 |
|
RU2822603C1 |
| DRUG FOR PREVENTION OR TREATMENT OF TAUPATHY | 2018 |
|
RU2739199C1 |
| DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS | 2005 |
|
RU2394570C2 |
